Cooperation needed among multi-lateral organisations to deal with future outbreaks: Adar Poonawalla
Speaking during the World Economic Forum (WEF) Annual Meeting 2023, Poonawalla said he is optimistic about the cooperation
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Serum Institute of India
SII seeks inclusion of COVID jab Covovax in CoWIN portal as heterologous booster dose for adults
The National Technical Advisery Group on Immunisation (NTAGI) is likely to hold a meeting soon to decide on the matter
Serum Institute’s free supply of Covishield to Centre : First lot of 80 lakh doses set for dispatch
Since the launch of the anti-COVID vaccination drive, SII has so far provided 170 crore doses of Covishield to the government
COVID-19: Covovax to get approval as booster in 10-15 days: Adar Poonawalla
He said everyone was looking at India, not just in terms of healthcare, but because the country managed to take care of a huge and…
Serum Institute seeks drug regulator’s approval for market authorisation of its COVID vaccine as…
The vaccine will be administered to those aged 18 years and above, and those who have been administered two doses of Covishield or…
Meeting on introduction of HPV vaccine in immunisation programme held; SII and Merck representatives…
Representatives of the Serum Institute of India (SII) and Merck were present in the meeting held last week and deliberated on…
SII manufactures and ships ebola vaccine to Uganda
The bivalent vaccine is designed to target both major strains of ebola virus
HPV vaccine production delayed due to COVID focus: SII
The Serum Institute of India (SII) will start supplying the HPV vaccine to the Indian government in early 2023